References

1.   Hull RD, Raskob GE, Hirsh J, et al: Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med 315:1109-14, 1986

2.   Barritt DW, Jordan SC: Anticoagulant drugs in the treatment of pulmonary embolism: A controlled trial. Lancet 1:1309-12, 1960

3.   Brathwaite CE, Mure AJ, OíMalley KF, et al: Complications of anticoagulation for pulmonary embolism in low risk trauma patients. Chest 104:718-20, 1993

4.   Hyers TM, Hull RD, Weg JG: Antithrombotic therapy for venous thromboembolic disease. Chest 95(S):37S-51S, 1989

5.   Wessler S, Gitel SN: Warfarin. From bedside to bench. N Engl J Med 311:645-52, 1984

6.   Coon WW, Willis PW 3rd, Symons MJ: Assessment of anticoagulant treatment of venous thromboembolism. Ann Surg 170:559-68, 1969

7.   Hull R, Hirsh J, Jay R, et al: Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J Med 307:1676-81, 1982

8.   Schulman S, Rhedin AS, Lindmarker P, et al: A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 332:1661-5, 1995

9.   Levine M, Gent M, Hirsh J, et al: A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 334:677-81, 1996

10.   Koopman MM, Prandoni P, Piovella F, et al: Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular weight heparin administered at home. N Engl J Med 334:682-7, 1996